| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/08/2007 | CA2236968C Accessory functions for use in recombinant aav virion production |
| 05/08/2007 | CA2137912C Combinatorial polypeptide antigens |
| 05/08/2007 | CA2102918C Genetic vaccine for immunodeficiency viruses |
| 05/03/2007 | WO2007050798A2 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer |
| 05/03/2007 | WO2007050769A2 Gene targets for enhanced carotenoid production |
| 05/03/2007 | WO2007050671A2 Fermentive production of four carbon alcohols |
| 05/03/2007 | WO2007050625A1 Modulation of triterpenoid content in plants |
| 05/03/2007 | WO2007050509A1 Maize promoter active in silks, stalk nodes, roots and leaf sheaths |
| 05/03/2007 | WO2007050103A2 Recombinant bacteria without selection marker |
| 05/03/2007 | WO2007050074A1 Conditionally replicating viruses and methods for cancer virotherapy |
| 05/03/2007 | WO2007050040A1 Immobilization unit and device for isolation of nucleic acid molecules |
| 05/03/2007 | WO2007049925A1 A novel hansenula polymorpha gene coding for dolichyl-phosphate-mannose dependent alpha-1,3-mannosyltransferase and process for the production of recombinant glycoproteins with hansenula polymorpha mutant strain deficient in the same gene |
| 05/03/2007 | WO2007049924A1 Recombinant adenovirus expressing a gene encoding streptolysin o protein and anti-cancer composition comprising same |
| 05/03/2007 | WO2007049829A1 Method for preparing soluble and active recombinant proteins using pdi as a fusion partner |
| 05/03/2007 | WO2007049827A1 Method of confirming probe-loading position in nucleic acid array |
| 05/03/2007 | WO2007049816A1 Plant capable of accumulating inorganic phosphate at high level and use of the plant |
| 05/03/2007 | WO2007049752A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
| 05/03/2007 | WO2007049749A1 Therapeutic method for blood coagulation disorder |
| 05/03/2007 | WO2007049737A1 Cytotoxic t-cell epitope peptide capable of specifically attacking cell infected with epstein-barr virus |
| 05/03/2007 | WO2007049731A1 Novel cell membrane-permeable peptide |
| 05/03/2007 | WO2007049730A1 Cytoplasmic hybrid plant belonging to the genus lactuca and method for production thereof |
| 05/03/2007 | WO2007049716A1 Novel plasmid vector and transformant capable of carrying plasmid stably |
| 05/03/2007 | WO2007049690A1 Formation/elongation of axon by inhibiting the expression or function of singar and application to nerve regeneration |
| 05/03/2007 | WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same |
| 05/03/2007 | WO2007049567A1 Method for production of substance |
| 05/03/2007 | WO2007049542A1 METHOD FOR PREDICTION OF EFFECTIVENESS OF RAR-α AGONIST |
| 05/03/2007 | WO2007049472A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 05/03/2007 | WO2007049416A1 Method for production of carotenoid-synthesizing microorganism and method for production of carotenoid |
| 05/03/2007 | WO2007049409A1 Recombinant hsv useful for treatment of human glioma |
| 05/03/2007 | WO2007049359A1 Method of controlling glucose metabolism |
| 05/03/2007 | WO2007049326A1 Nucleic acid extraction method and nucleic acid extraction kit |
| 05/03/2007 | WO2007049118A1 Genetic variants of human inositol polyphosphate-4-phosphatase, type i (inpp4a) useful for prediction and therapy of immunological disorders |
| 05/03/2007 | WO2007049095A1 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof |
| 05/03/2007 | WO2007049074A2 Modulation of 11beta-hydroxysteroid dehydrogenase 1 expression for the treatment of ocular diseases |
| 05/03/2007 | WO2007049036A2 Transgenic plant cells expressing a transcription factor relating to seed dormancy |
| 05/03/2007 | WO2007048849A1 Fusion proteins that bind effector lymphocytes and target cells |
| 05/03/2007 | WO2007048780A2 Nucleic acid molecules encoding phosphatidate cytidylyl-transferase-like polypeptides and methods of use |
| 05/03/2007 | WO2007048644A2 Prevention of retroviral infectivity through interference with ppt |
| 05/03/2007 | WO2007048629A2 Modulation of rna silencing efficiency by argonaute proteins |
| 05/03/2007 | WO2007048628A2 Structures of active guide rna molecules and method of selection |
| 05/03/2007 | WO2007048618A1 Method for enhancing somatic hypermutation, gene conversion and class switch recombination |
| 05/03/2007 | WO2007048601A1 Protein expression in rodent cells |
| 05/03/2007 | WO2007048254A1 Hepatitis c virus ns2/3 activity assay |
| 05/03/2007 | WO2007048235A1 A novel gene encoding amorphadiene hydroxylase and a process to produce artemisinic alcohol therewith |
| 05/03/2007 | WO2007048207A1 Specific expression using transcriptional control sequences in plants |
| 05/03/2007 | WO2007048202A1 Methods and compositions for modulating wound repair |
| 05/03/2007 | WO2007048189A1 Modification of flavonoid biosynthesis in plants |
| 05/03/2007 | WO2007030803A3 Method for preparing trimeric proteins |
| 05/03/2007 | WO2007028610A3 Novel gene gms 08 |
| 05/03/2007 | WO2007024870A3 Rubisco activase with increased thermostability and methods of use thereof |
| 05/03/2007 | WO2007022506A3 Methods and compositions for treating neurological disease |
| 05/03/2007 | WO2007022416A3 Single chain antibodies against beta-amyloid peptide |
| 05/03/2007 | WO2007020295A3 Microorganisms with increased efficiency for methionine synthesis |
| 05/03/2007 | WO2007011941A3 Human anti-b7rp1 neutralizing antibodies |
| 05/03/2007 | WO2006138560A3 Nucleic acid-templated chemistry in organic solvents |
| 05/03/2007 | WO2006125012A3 Compositions, methods and kits for real-time nucleic acid analysis in live cells |
| 05/03/2007 | WO2006124626A3 Inhibition of the 44 kilodalton isoform of pim-1 kinase restores apoptosis induced by chemotherapeutic drugs in cancer cells |
| 05/03/2007 | WO2006117250A3 Importation of mitochondrial protein by an enhanced allotopic approach |
| 05/03/2007 | WO2006109192A8 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 05/03/2007 | WO2006079045A3 Evaluation of salt tolerance in transgenic arabidopsis plants expressing sos2 mutant alleles . |
| 05/03/2007 | WO2006073496A3 Recombinant aav based vaccine methods |
| 05/03/2007 | WO2006071410A3 Apparatus and system having dry gene silencing compositions |
| 05/03/2007 | WO2006060376A3 Stress tolerance in plants through selective inhibition of trehalose-6-phosphate phosphatase |
| 05/03/2007 | WO2006030455A8 Dna polymerases having strand displacement activity |
| 05/03/2007 | WO2006017276A3 Recombinant rabies virus compositions |
| 05/03/2007 | WO2005103270A3 Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants |
| 05/03/2007 | WO2005092069A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 05/03/2007 | WO2005091716A8 Annexin ii and uses thereof |
| 05/03/2007 | WO2005037989A3 Binding domain-immunoglobulin fusion proteins |
| 05/03/2007 | WO2005026317A3 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3 |
| 05/03/2007 | WO2005010156A3 Genes encoding carotenoid compounds |
| 05/03/2007 | WO2004111198A3 Modified human acid sphingomyelinase having increased activity, and methods for making the same |
| 05/03/2007 | WO2004093778A3 Oligonucleotides that block toll-like receptors |
| 05/03/2007 | WO2004065575A3 Dna compositon and uses thereof |
| 05/03/2007 | WO2004018643A3 Method for regulating dopamine producing cells |
| 05/03/2007 | WO2003052049A3 Molecules for disease detection and treatment |
| 05/03/2007 | WO2001011074A3 Nucleic acids encoding zinc metalloproteases |
| 05/03/2007 | US20070101460 Nucleotide sequences and polypeptides encoded thereby useful for producing transformed plants expressing lethal/nonviability genes |
| 05/03/2007 | US20070101459 Conditional sterility in plants |
| 05/03/2007 | US20070101458 Plant seed-specific expression promoter derived from sesame and seed-specific expression vector comprising the promoter |
| 05/03/2007 | US20070101457 Methods of controlling reproduction in plants |
| 05/03/2007 | US20070101456 Enlargement and new use of soybean endosperm tissue |
| 05/03/2007 | US20070101455 Castanea sativa mill. genes codifying for allene oxide cyclase, cystatin, beta-1, 3-glucanase and thaumatin-like protein and their use |
| 05/03/2007 | US20070101454 Transgenic plants having increased soluble solids, lycopene, and improved plant volume or yield, increased anthocyanin in leaves, seedling vigor; improved resistance to cold, heat, freezing, low nitrogen and phosphorus conditions, osmotic stresses such as drought, and high salt |
| 05/03/2007 | US20070101452 Method for creating fusion protein and conditional alleles |
| 05/03/2007 | US20070101451 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/03/2007 | US20070101450 DNA that encodes a protein having high-affinity choline transporter activity |
| 05/03/2007 | US20070101449 Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site |
| 05/03/2007 | US20070101447 Diagnostic tests for the detection of motor neuropathy |
| 05/03/2007 | US20070101446 Antibodies against epitopes with homology to self antigens, methods of preparation |
| 05/03/2007 | US20070101444 Ion channel |
| 05/03/2007 | US20070101443 Animal models; drug screening; uridine diphospho-glucuronosyl transferase; predicting likely behaviour of a drug in a selected species of primate |
| 05/03/2007 | US20070100561 Crystals of DPP-IV |
| 05/03/2007 | US20070100559 Crystal structure of a deacetylase and inhibitors thereof |
| 05/03/2007 | US20070100133 Erythropoietic compounds |
| 05/03/2007 | US20070099862 Sequence specific gene silencing; antisense agents |
| 05/03/2007 | US20070099860 Double-stranded ribonucleic acid (dsRNA), mediating RNA interference, Huntington's disease |
| 05/03/2007 | US20070099858 RNA interference mediated of inhibition of influenza virus gene expression using short interfering nucleic acid (siNA) |
| 05/03/2007 | US20070099857 Methods and means for inhibiting fever |
| 05/03/2007 | US20070099296 Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs |